Related references
Note: Only part of the references are listed.Hypoalbuminemia as Surrogate and Culprit of Infections
Christian J. Wiedermann
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Novel Correction Equation Avoids High-Magnitude Errors in Interpreting Therapeutic Drug Monitoring of Phenytoin Among Critically Ill Patients
Megan E. Barra et al.
THERAPEUTIC DRUG MONITORING (2020)
Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Neurocritical Care Unit
Mandee Noval et al.
DRUGS IN R&D (2020)
Safety range of free valproic acid serum concentration in adult patients
Yu-Ju Tseng et al.
PLOS ONE (2020)
Antiseizure medications in critical care: an update
Baxter Allen et al.
CURRENT OPINION IN CRITICAL CARE (2019)
Antiepileptic drugs in critically ill patients
Salia Farrokh et al.
CRITICAL CARE (2018)
Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review
Richard R. Riker et al.
PHARMACOTHERAPY (2017)
A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations
Tony K. L. Kiang et al.
ANNALS OF PHARMACOTHERAPY (2016)
Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy
Keaton S. Smetana et al.
JOURNAL OF CRITICAL CARE (2016)
Characterization of Unbound Phenytoin Concentrations in Neurointensive Care Unit Patients Using a Revised Winter-Tozer Equation
Sean P. Kane et al.
ANNALS OF PHARMACOTHERAPY (2013)
When is Protein Binding Important?
Jules Heuberger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Seizures and the Neurosurgical Intensive Care Unit
Panayiotis N. Varelas et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2013)
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Yogita Ghodke-Puranik et al.
PHARMACOGENETICS AND GENOMICS (2013)
PharmGKB summary: phenytoin pathway
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2012)
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Philip N. Patsalos et al.
EPILEPSIA (2008)
Therapeutic Drug Monitoring of Phenytoin in Critically Ill Patients
Sandrina L. von Winckelmann et al.
PHARMACOTHERAPY (2008)
Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children
Gerhard K. Wolf et al.
PEDIATRIC CRITICAL CARE MEDICINE (2006)
A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients
J Hermida et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Drugs pharmacokinetics in ICU patients: consequences of hypoalbuminemia upon drugs monitoring and dosing scheme
F Lagneau et al.
INTENSIVE CARE MEDICINE (2004)